- Serious arterial and venous thrombotic events have been reported in clinical trials and postmarketing surveillance
- Patients with congenital hemophilia receiving concomitant treatment with aPCCs (activated prothrombin complex concentrates), older patients particularly with acquired hemophilia and receiving other hemostatic agents, and patients with a history of cardiac and vascular disease may have an increased risk of developing thrombotic events

Podcast
Recognizing Rare Bleeding Disorders
Dr. Miguel Escobar discusses how hematologists and oncologists can diagnose and treat unexplained bleeds in patients with acquired hemophilia.
Recognizing Rare Bleeding Disorders
Dr. Miguel Escobar discusses how hematologists and oncologists can diagnose and treat unexplained bleeds in patients with acquired hemophilia.